Biotech Archives - Page 133 of 795

2 minute read

Affimed Provides Clinical Response Update On AFM24-102 Trial In EGFR-Wildtype Non-Small Cell Lung Cancer

January 8, 5:16 PM

Data update from AFM24-102 Phase 1/2a combination study includes 15 heavily pre-treated patients from the EGFR-wildtype (wt) non-small cell lung cancer (NSCLC) expansion cohortFollow-up shows three of the initially

AFMD

1 minute read

Why Is Heart Failure Drug-Focused Cytokinetic Stock Trading Higher Today?

By Vandana Singh

January 8, 3:24 PM

Cytokinetics Inc (NASDAQ: CYTK) shares are trading higher after a report on potential takeover talks with Novartis AG (NYSE: NVS).

CYTK

1 minute read

Why Is $7B Valued Cancer Focused Exelixis Trading Lower Today?

By Vandana Singh

January 8, 3:12 PM

Sunday, Exelixis Inc (NASDAQ: EXEL) provided financial guidance for fiscal year 2024 and delivered an

EXEL

2 minute read

Menopause Management: Bayer’s Non-Hormonal Treatment Option Shows Efficacy In Trial

By Vandana Singh

January 8, 2:11 PM

Monday, Bayer AG (OTC: BAYRY (OTC: BAYZF)

BAYRY

3 minute read

FDA Approves Medtronic Percept RC Neurostimulator With Exclusive BrainSense Technology

By Benzinga Newsdesk

January 8, 1:39 PM

Rechargeable neurostimulator joins the Medtronic Percept™ family – the first and only deep brain stimulation system with sensing, directionality, and advanced programming.DUBLIN, Jan. 8, 2024

MDT

1 minute read

Predicine Announces Collaboration With Janssen To Develop PredicineCARE As A Companion Diagnostic Assay In Localized Bladder Cancer

By Benzinga Newsdesk

January 8, 1:08 PM

Collaboration Utilizing PredicineCARE™ Urine cfDNA NGS Assay Marks Progress in Employing Comprehensive Genomic Profiling for Detection of Select Alterations in Localized Bladder CancerPredicine, Inc., a leading

JNJ

1 minute read

Why Is Cancer-Focused Cellectar Biosciences Stock Trading Higher Today?

By Vandana Singh

January 8, 12:15 PM

Cellectar Biosciences Inc (NASDAQ: CLRB) announced data from its CLOVER WaM pivotal study, evaluating iopofosine I 131, a targeted radiotherapy candidate for the treatment of relapsed/refractory Waldenstrom's macroglobulinemia (WM) patients that have received at

CLRB

2 minute read

Wegovy and Ozempic Maker Novo Nordisk Shares Data From Phase 3 Diabetes Study Of Semaglutide/Insulin Containing Candidate

By Vandana Singh

January 8, 12:11 PM

Novo Nordisk A/S (NYSE: NVO) announced topli

NVO

4 minute read

European Commission Approves Pfizer’s TALZENNA In Combination With XTANDI For Adult Patients With Metastatic Castration-Resistant Prostate Cancer

By Benzinga Newsdesk

January 8, 11:35 AM

TALZENNA is the first and only PARP inhibitor approved in combination with standard of care XTANDI for mCRPC patients in the Europe UnionPfizer Inc. (NYSE:PFE) today announced that the European Commission (EC) has

PFE

4 minute read

Palatin Provides Corporate Update And Highlights Strategic Priorities For Calendar Year 2024; Completed Asset Sale To Cosette Pharmaceuticals For Up To $171M; $12M Upfront Plus Sales-Based Milestones Of Up To $159M

By Benzinga Newsdesk

January 8, 11:34 AM

Dry Eye Disease (DED): PL9643 MELODY-1 Phase 3 StudyData Base Lock 2H January 2024Topline Data Readout Expected Early 1Q Calendar Year 2024Ulcerative Colitis (UC): Oral PL8177 Phase 2 Clinical Study in Active UC

PTN